###begin article-title 0
###xml 116 122 <span type="species:ncbi:9606">humans</span>
Gene duplications resulting in over expression of glucokinase are not a common cause of hypoglycaemia of infancy in humans
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin p 2
###xml 185 190 185 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1 bib2" ref-type="bibr">[1,2]</xref>
###xml 315 320 312 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3 bib4" ref-type="bibr">[3,4]</xref>
###xml 607 636 604 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hypoglycaemia of infancy (HI)</italic>
###xml 760 763 757 760 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP</sub>
###xml 786 791 783 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 805 811 802 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 827 830 824 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 884 889 881 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUD1</italic>
###xml 940 945 937 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCHAD</italic>
###xml 1001 1003 998 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HI</italic>
###xml 1003 1006 1000 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5" ref-type="bibr">[5]</xref>
###xml 1008 1011 1005 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 1091 1092 1088 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1101 1103 1098 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HI</italic>
###xml 1226 1229 1223 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6" ref-type="bibr">[6]</xref>
###xml 1435 1438 1432 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr">[7]</xref>
###xml 1247 1255 <span type="species:ncbi:9606">patients</span>
It is well established that chromosome rearrangements and duplications which result in the loss of or the over expression of gene(s) can result in syndromes which feature hypoglycaemia [1,2]. More recently studies have demonstrated the importance of "gene dosage" in monogenic disorders of the pancreatic beta-cell [3,4]. Investigators routinely screen for mutations using the gold standard methodology of direct sequencing of the coding regions and conserved splice sites of the gene of interest, however this method does not detect heterozygous deletions or duplications of one or more exons of the gene. Hypoglycaemia of infancy (HI) is a rare condition characterised by unregulated insulin secretion despite hypoglycaemia. Mutations in genes encoding the KATP-channel subunits SUR1(ABCC8) and Kir6.2 (KCNJ11), glucokinase (GCK), the mitochondrial enzymes glutamate-dehydrogenase (GLUD1) and short-chain 3-hydroxyacyl-CoA-dehydrogenase (SCHAD) are responsible for approximately 50% of the cases of HI[5]. GCK activating mutations have been reported in a relatively small number of cases (n = 7) of HI and are characterised by regulated insulin secretion albeit at a reduced threshold for glucose stimulated insulin release [6]. The majority of patients can be treated successfully with the potassium channel opener diazoxide or with diet treatment alone, although cases that have undergone partial pancreatectomy have been reported [7].
###end p 2
###begin p 3
###xml 124 130 124 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8 bib9 bib10" ref-type="bibr">[8&#8211;10]</xref>
###xml 163 166 163 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 334 337 331 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 379 381 376 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HI</italic>
###xml 433 435 430 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HI</italic>
###xml 538 541 535 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 559 562 556 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 703 705 700 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HI</italic>
###xml 707 708 704 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 783 790 780 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 841 844 838 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 937 943 934 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4 bib11" ref-type="bibr">[4,11]</xref>
###xml 968 971 965 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 1119 1121 1116 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HI</italic>
###xml 1170 1173 1167 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 1300 1303 1297 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 1358 1360 1355 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HI</italic>
###xml 752 760 <span type="species:ncbi:9606">patients</span>
###xml 1001 1009 <span type="species:ncbi:9606">patients</span>
###xml 1125 1131 <span type="species:ncbi:9606">humans</span>
A number of studies in rodents have shown than over expression of the glucokinase gene results in increased enzyme activity [8-10]. Over expression resulting from GCK gene duplications would result in increased liver and beta-cell glucokinase activity and could therefore result in hypoglycaemia. We hypothesised that duplications of GCK might play a role in the pathogenesis of HI and account for the significant number of cases of HI of unknown genetic aetiology. To determine the putative role of partial or whole gene duplications of GCK, we screened the GCK gene for copy number variation using a multiplex ligation-dependent probe amplification (MLPA) assay in unrelated subjects with unexplained HI (n = 33). The clinical characteristics of the patients screened are shown in Table 1. The MLPA assays were performed using a synthetic GCK probe mix as reported by Ellard et al. and the data was analysed as described by Lai et al. [4,11]. No duplications of the GCK gene were detected in the 33 patients screened. Our data therefore suggest that over expression of glucokinase is unlikely to be a common cause of HI in humans but does not exclude rare cases where GCK duplications may contribute to a lowering of blood glucose levels. In conclusion, there is no evidence to support including a GCK dosage assay in the diagnostic testing repertoire for HI.
###end p 3
###begin title 4
Acknowledgments
###end title 4
###begin p 5
The authors thank Sarah Flanagan for her technical assistance. This work was supported in Oxford by the Medical Research Council. MvdB acknowledges the support of the Dutch Diabetes Research Foundation.
###end p 5
###begin title 6
References
###end title 6
###begin article-title 7
Molecular genetics of Wiedemann-Beckwith syndrome
###end article-title 7
###begin article-title 8
A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene
###end article-title 8
###begin article-title 9
Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5
###end article-title 9
###begin article-title 10
Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young
###end article-title 10
###begin article-title 11
Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates
###end article-title 11
###begin article-title 12
Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy
###end article-title 12
###begin article-title 13
GK linked hypoglycemia: clinical aspects of activating glucokinase mutations
###end article-title 13
###begin article-title 14
###xml 90 94 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia
###end article-title 14
###begin article-title 15
Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism
###end article-title 15
###begin article-title 16
Correction of diabetic alterations by glucokinase
###end article-title 16
###begin article-title 17
Detecting exon deletions and duplications of the DMD gene using multiplex ligation-dependent probe amplification (MLPA)
###end article-title 17
###begin p 18
Clinical Characteristics of subjects studied
###end p 18
###begin p 19
Data are mean (SEM).
###end p 19
###begin p 20
Fasting glucose measurement.
###end p 20

